IDS-iSYS N-Mid® Osteocalcin, Catalog Number IS-2900. Packaged in cardboard Box containing plastic bottles. The IDS-iSYS N-Mid® Osteocalcin Assay is intended for the quantitative determination of Osteocalcin in human serum or plasma on the IDS-iSYS Multi-Discipline Automated Analyser (Analyser). Results are to be used in conjunction with other clinical and laboratory data to assist the clinician. Osteocalcin is an indicator of osteoblastic activity in human serum and plasma and is intended to be used as an aid in the prevention of osteoporosis.
Published October 17, 2012 · Recall initiated: August 10, 2012
Summary
FDA records medical device Class II recall Z-0042-2013, published October 17, 2012 and initiated August 10, 2012. Recalling firm: Immunodiagnostics Systems Ltd; Status: Terminated; Reported quantity: 5; Lot: Lot 948 and 1145, EXP Aug 2012 and Jan 2013 respectively. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
It has been noted by staff at IDS Inc. that stock of the affected products held at IDS Inc. are labeled with IVD labels although they are not registered for sale as IVDs in the United States. The products should have been labeled as Research Use Only or Investigational use only dependent on their usage.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Immunodiagnostics Systems Ltd
- Distributor
- Nationwide Distribution including NY, CA, ME and CT.
- Lot
- Lot 948 and 1145, EXP Aug 2012 and Jan 2013 respectively
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United Kingdom
Related recalls
- FDAIDS Urine BETA CrossLaps ELISA, Catalog Number AC-05F1. Type of packaging: Cardboard Box containing plasticOctober 17, 2012
- FDAIDS-iSYS Ostase® BAP (Bone Alkaline Phosphatase) Control Set, Catalog Number IS-2830. Packaged in cardboardOctober 17, 2012
- FDAIDS-iSYS Intact PINP Control Set, Catalog Number IS-4030. Packaged in cardboard Box containing plasticOctober 17, 2012
- FDAIDS-iSYS N-Mid® Osteocalcin, Catalog Number IS-2930. Packaged in cardboard Box containing plastic bottles. TheOctober 17, 2012
- FDAIDS-iSYS Ostase® BAP (Bone Alkaline Phosphatase), Catalog Number IS-2800. Packaged in cardboard Box containingOctober 17, 2012
- FDAIDS-iSYS Intact PINP, Catalog Number IS-4000. Packaged in cardboard Box containing plastic bottles. TheOctober 17, 2012
Questions about this recall
Was IDS-iSYS N-Mid® Osteocalcin, Catalog Number IS-2900. Packaged in cardboard Box containing plastic bottles. The IDS-iSYS N-Mid® Osteocalcin Assay is intended for the quantitative determination of Osteocalcin in human serum or plasma on the IDS-iSYS Multi-Discipline Automated Analyser (Analyser). Results are to be used in conjunction with other clinical and laboratory data to assist the clinician. Osteocalcin is an indicator of osteoblastic activity in human serum and plasma and is intended to be used as an aid in the prevention of osteoporosis. recalled?
Yes. FDA published recall Z-0042-2013 on October 17, 2012. Reported hazard: It has been noted by staff at IDS Inc. that stock of the affected products held at IDS Inc. are labeled with IVD labels although they are not registered for sale as IVDs in the United States. The products should have been labeled as Research Use Only or Investigational use only dependent on their usage.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail